Kwamina Thomas Williford is a partner with the firm's Litigation Department and a member of the firm's Compliance Services Team and White Collar Team. She represents clients in internal investigations responding to and anticipating government inquiries by various government agencies related to alleged fraudulent activity, such as the False Claims Act. Ms. Williford draws upon her experience to advise clients on the design and implementation of compliance programs for government contractors, higher education institutions and other highly regulated entities. She also represents clients before courts and administrative agencies related to contract disputes, statutory violations and D.C. regulatory matters.
Prior to joining Holland & Knight, Ms. Williford served as a law clerk for the Honorable Gerald Bruce Lee in the United States District Court for the Eastern District of Virginia.
Representative matters include:
- defended medical device company in an investigation by the state attorney general in connection with False Claims Act allegations
- conducted internal investigation of medical rehabilitation organization in connection with potential False Claims Act violations
- conducted internal investigation of government contractor facing potential False Claims Act violations
- led internal investigation into potential fraud and misuse of earmark funding for non-profit organization
- defended pharmaceutical manufacturing company in a Department of Justice investigation involving claims regarding kickbacks, false claims, and off-label promotion
- participated in internal investigation involving Foreign Corrupt Practices Act matters
- conducted internal employment investigation involving claims of harassment
- advised pharmaceutical manufacturing company on numerous compliance policies and procedures
- advised national company regarding the development of a practical and cost effective records retention program and the implementation of e-discovery best practices
- advised higher education institution regarding the development of a comprehensive compliance program
- represented pharmaceutical company in congressional investigation by the U.S. House of Representatives’ Energy and Commerce Committee related to the contamination of a drug supply chain
- represented chemical company in congressional investigation by the U.S. House of Representatives’ Energy and Commerce Committee related to concerns with flame resistant materials